US Bancorp’s Ocugen OCGN Stock Holding History

US Bancorp’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$287	Buy	+279	New	+$355	﹤0.01%	4165
2025 Q1	–	Sell	-1,238	Closed	-$997	–	4317
2024 Q4	$997	Sell	1,238 -400	-24%	-$366	﹤0.01%	3957
2024 Q3	$1.62K	Sell	1,638 -1,888	-54%	-$2.59K	﹤0.01%	3830
2024 Q2	$5.46K	Buy	+3,526	New	+$5.49K	﹤0.01%	3484
2023 Q2	–	Sell	-2,833	Closed	-$2.42K	–	4090
2023 Q1	$2.42K	Buy	2,833 +285	+11%	+$311	﹤0.01%	3709
2022 Q4	$3.31K	Buy	2,548 +914	+56%	+$1.42K	﹤0.01%	3642
2022 Q3	$3K	Sell	1,634 -1,679	-51%	-$4.18K	﹤0.01%	3746
2022 Q2	$8K	Sell	3,313 -1,203	-27%	-$2.88K	﹤0.01%	3434
2022 Q1	$15K	Buy	4,516 +1,679	+59%	+$5.9K	﹤0.01%	3225
2021 Q4	$13K	Buy	2,837 +1,802	+174%	+$13.6K	﹤0.01%	3326
2021 Q3	$7K	Buy	+1,035	New	+$7.6K	﹤0.01%	3557

Other funds holding OCGN

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Procyon Advisors Shelton, Connecticut $2.36B AUM 20.32% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

US Bancorp's OCGN Position: Q3 2026 in Review

US Bancorp opened a new position in Ocugen (OCGN) in Q3 2026: 279 shares worth $287. The stake represents ﹤0.01% of the portfolio and ranks #4165 among its holdings. This is a return to the name: US Bancorp previously reported a position in OCGN as recently as Q4 2024.

US Bancorp first reported a position in OCGN in Q3 2021 and has held it in 11 quarters since. The position peaked at $15K in Q1 2022. 69 funds tracked by Wall St. Rank hold OCGN as of Q3 2026.

US Bancorp held 279 shares of Ocugen worth $287 as of Q3 2026.
Ocugen was a new US Bancorp position in Q3 2026.
Ocugen made up ﹤0.01% of US Bancorp's portfolio in Q3 2026, its #4165 holding.
US Bancorp first reported a position in Ocugen in Q3 2021 and has held it in 11 quarters since.
US Bancorp's Ocugen position peaked at $15K in Q1 2022.
69 funds tracked by Wall St. Rank held Ocugen as of Q3 2026.

Based on US Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.